ECM
EGRX

Everence Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Everence Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,970
Closed -$221K – 751
2022
Q2 		$221K Buy
+4,970
New +$221K 0.02% 608